Zobrazeno 1 - 10
of 50
pro vyhledávání: '"Michael C Kirchberger"'
Autor:
Anju Nohria, Alexander R Lyon, Stephane Ederhy, Franck Thuny, Michael Mahmoudi, Magid Awadalla, Dahlia Banerji, Merna Armanious, Dipti Gupta, Sarju Ganatra, Paaladinesh Thavendiranathan, Gagan Sahni, Ryan Sullivan, Lili Zhang, Tomas G Neilan, Daniel A Zlotoff, Malek Z O Hassan, Amna Zafar, Raza M Alvi, Syed S Mahmood, Carol L Chen, Ana Barac, Maeve Jones-O'Connor, Sean P Murphy, Brian J Forrestal, Michael C Kirchberger, Otavio R Coelho-Filho, Muhammad A Rizvi, Anant Mandawat, Carlo G Tocchetti, Sarah Hartmann, Hannah K Gilman, Eduardo Zatarain-Nicolás, Lucie M Heinzerling, Justine V Cohen, John Groarke, Michael G Fradley
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss 3 (2021)
Background Myocarditis is a highly morbid complication of immune checkpoint inhibitor (ICI) use that remains inadequately characterized. The QRS duration and the QTc interval are standardized electrocardiographic measures that are prolonged in other
Externí odkaz:
https://doaj.org/article/e0d49c053cc347dfa4d4fbdd78de84e0
Autor:
Markus V. Heppt, Teresa Amaral, Katharina C. Kähler, Lucie Heinzerling, Jessica C. Hassel, Markus Meissner, Nicole Kreuzberg, Carmen Loquai, Lydia Reinhardt, Jochen Utikal, Evelyn Dabrowski, Anja Gesierich, Claudia Pföhler, Patrick Terheyden, Kai-Martin Thoms, Lisa Zimmer, Thomas K. Eigentler, Michael C. Kirchberger, Henner M. Stege, Friedegund Meier, Max Schlaak, Carola Berking
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 7, Iss 1, Pp 1-9 (2019)
Abstract Background Uveal melanoma (UM) is highly refractory to treatment with dismal prognosis in advanced stages. The value of the combined checkpoint blockade with CTLA-4 and PD-1 inhibition in metastatic UM is currently unclear. Methods Patients
Externí odkaz:
https://doaj.org/article/39e18ef3acc940829b41d0958141f699
Autor:
Theresa Steeb, Anja Wessely, Heike Merkl, Michael C. Kirchberger, Caroline Voskens, Michael Erdmann, Lucie Heinzerling, Carola Berking, Markus V. Heppt
Publikováno v:
Acta Dermato-Venereologica, Vol 101, Iss 6, p adv00482 (2021)
An important measure of hospital quality is the satisfaction of patients. The aim of this cross-sectional study, performed in the dermato-oncology unit of the university hospital in Erlangen, Germany, was to assess skin cancer patients’ degree of s
Externí odkaz:
https://doaj.org/article/4235e391fd95414fa60de17709833e62
Autor:
Justin Gabriel Schlager, Rahel M. Strobel, Johannes C. Lauscher, Michael C. Kirchberger, Kreis, Pd Dr. med. JohannesChristian Lauscher, Martin, Cornelia Erfurt-Berge
Publikováno v:
ProCare. 26:35-46
Autor:
Waltraud Fröhlich, Lucie Heinzerling, Beate Husain, Carola Berking, Sabine Schüpferling, Amir-Reza Abolhassani, Michael Erdmann, Michael C. Kirchberger
Publikováno v:
Journal of Cancer Research and Clinical Oncology
Purpose Immune checkpoint inhibitors (ICI) are highly effective in several cancer entities, but also invoke a variety of immune-related adverse events (irAE). These are mostly reversible, but can be life-threatening or even fatal. Currently, the path
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::da0222b1be4d02a63de1dc56d3ef543a
https://opus4.kobv.de/opus4-fau/frontdoor/index/index/docId/22122
https://opus4.kobv.de/opus4-fau/frontdoor/index/index/docId/22122
Publikováno v:
Zeitschrift für Gerontologie und Geriatrie. 53:572-576
Maligne Wunden entstehen entweder primar oder sekundar im Sinne einer malignen Transformation in bereits bestehenden Wunden. Eine Vielzahl von Hauttumorerkrankungen wie z. B. Basaliome, Plattenepithelkarzinome, Melanome und Lymphome, aber auch kutane
Autor:
Alvaro Moreira, Michael Erdmann, Lucie Heinzerling, Stefanie Gross, Gerold Schuler, Michael C. Kirchberger
Publikováno v:
International Journal of Cancer. 144:1147-1150
Recent studies suggest that the age-related remodeling of the immune system, known as immunosenescence, could impact the efficacy of immune checkpoint inhibitors in leukemia or nonsmall cell lung cancer. We investigated whether senescence markers can
Autor:
Eduardo Zatarain-Nicolás, Nahikari Salterain González, Sarju Ganatra, Paaladinesh Thavendiranathan, Jonathan W. Weinsaft, Eric H. Yang, Ana González-Mansilla, Zsofia D. Drobni, Oscar Calvillo-Argüelles, Michael G. Fradley, Sarah Hartmann, Francisco Fernández-Avilés, Caroline Michel, Bojan Kovacina, Lili Zhang, Marcella Cabral, Manuel Garcia De Yebenes Castro, Gagan Sahni, Magid Awadalla, Syed S. Mahmood, Antonio Calles, Hannah K Gilman, Daniel A. Zlotoff, Franck Thuny, Bernd J. Wintersperger, Ryan J. Sullivan, Alexander R. Lyon, Dipti Gupta, Jonathan Afilalo, Michael Mahmoudi, Kerry L. Reynolds, Lucie Heinzerling, Juan José Gavira, Amna Zafar, Raymond Y. Kwong, Anju Nohria, Muhammad A. Rizvi, Ana Barac, Michael Jerosch-Herold, Tomas G. Neilan, Otavio R. Coelho-Filho, Michael C. Kirchberger, Stéphane Ederhy, Carol L. Chen, A. John Baksi
Publikováno v:
Journal of the American College of Cardiology
Journal of the American College of Cardiology, Elsevier, 2021, 77 (12), pp.1503-1516. ⟨10.1016/j.jacc.2021.01.050⟩
Journal of the American College of Cardiology, 2021, 77 (12), pp.1503-1516. ⟨10.1016/j.jacc.2021.01.050⟩
J Am Coll Cardiol
Journal of the American College of Cardiology, Elsevier, 2021, 77 (12), pp.1503-1516. ⟨10.1016/j.jacc.2021.01.050⟩
Journal of the American College of Cardiology, 2021, 77 (12), pp.1503-1516. ⟨10.1016/j.jacc.2021.01.050⟩
J Am Coll Cardiol
International audience; BACKGROUND Myocarditis is a potentially fatal complication of immune checkpoint inhibitor (ICI) therapy. Data on the utility of cardiovascular magnetic resonance (CMR) T1 and T2 mapping in ICI myocarditis are limited.OBJECTIVE
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0ef55e5abb49dac6039fb3dbb18adbe0
https://hal.inrae.fr/hal-03328786
https://hal.inrae.fr/hal-03328786
Autor:
Justine V. Cohen, Dahlia Banerji, Anant Mandawat, Syed S. Mahmood, Maeve Jones-O'Connor, Malek Z.O. Hassan, Eric H. Yang, Alexander R. Lyon, Franck Thuny, Carlo G. Tocchetti, Brian J. Forrestal, Sarju Ganatra, Ryan J. Sullivan, Carol L. Chen, Lili Zhang, Michael G. Fradley, Eduardo Zatarain-Nicolás, Daniel A. Zlotoff, Merna Armanious, Sean P. Murphy, Magid Awadalla, Dipti Gupta, Gagan Sahni, Paaladinesh Thavendiranathan, Sarah Hartmann, Hannah K Gilman, Raza M. Alvi, Leyre Zubiri, Kerry L. Reynolds, Muhammad A. Rizvi, Lucie Heinzerling, Ana Barac, Otavio R. Coelho-Filho, John D. Groarke, Michael Mahmoudi, Amna Zafar, Michael C. Kirchberger, Stéphane Ederhy, Tomas G. Neilan, Anju Nohria
Publikováno v:
Journal for Immunotherapy of Cancer
Journal for immunotherapy of cancer, vol 9, iss 3
Journal for ImmunoTherapy of Cancer, Vol 9, Iss 3 (2021)
Journal for Immunotherapy of Cancer, 2021, 9 (3), pp.e002007. ⟨10.1136/jitc-2020-002007⟩
Journal for immunotherapy of cancer, vol 9, iss 3
Journal for ImmunoTherapy of Cancer, Vol 9, Iss 3 (2021)
Journal for Immunotherapy of Cancer, 2021, 9 (3), pp.e002007. ⟨10.1136/jitc-2020-002007⟩
BackgroundMyocarditis is a highly morbid complication of immune checkpoint inhibitor (ICI) use that remains inadequately characterized. The QRS duration and the QTc interval are standardized electrocardiographic measures that are prolonged in other c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::899a75fe04ca859b21c0ebf94d3d9d6a
http://hdl.handle.net/11588/848966
http://hdl.handle.net/11588/848966
Autor:
Eduardo Zatarain-Nicolás, Anant Mandawat, Muhammad A. Rizvi, Sarju Ganatra, Ana Barac, Justine V. Cohen, Michael G. Fradley, Brian J. Forrestal, Magid Awadalla, Lucie Heinzerling, Syed S. Mahmood, Lili Zhang, Leyre Zubiri, Alexander R. Lyon, Stéphane Ederhy, Gagan Sahni, Carol L. Chen, Maeve Jones-O'Connor, Malek Z.O. Hassan, Paaladinesh Thavendiranathan, Ryan J. Sullivan, Anju Nohria, Eric H. Yang, Adam Rokicki, Michael C. Kirchberger, Daniel A. Zlotoff, Dipti Gupta, Sean P. Murphy, Raza M. Alvi, Sachin P. Shah, Tomas G. Neilan, Kerry L. Reynolds, John D. Groarke, Michael Mahmoudi, Franck Thuny, Carlo G. Tocchetti
Publikováno v:
Circulation
Circulation, vol 141, iss 24
Circulation, vol 141, iss 24
Introduction: myocarditis is a potentially fatal complication of immune checkpoint inhibitors (ICI). While corticosteroids are the cornerstones of the treatment, there are no data to guide the dose and timing. Methods: from an international registry